Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation

Unrelated umbilical cord blood can improve the prognosis of haploidentical hematopoietic stem cell transplantation

Abstract Background Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is widely used as a curative treatment strategy for most types of hematological diseases. However, strategies for enhancing the graft versus leukemia (GVL) effect without aggravating the graft versus host disease...

Full description

Bibliographic Details
Main Authors:	Ying Yang, Ming Zhang, Mengqi Li, Yingchun Li, Wei Yang, Zhuogang Liu, Hongtao Wang
Format:	Article
Language:	English
Published:	BMC 2022-09-01
Series:	Stem Cell Research & Therapy
Subjects:	Haploidentical hematopoietic stem cell transplantation Unrelated umbilical cord blood Graft versus leukemia Graft versus host disease Prognosis
Online Access:	https://doi.org/10.1186/s13287-022-03170-x

Similar Items

Umbilical cord blood stem cells as third-party adjuvant infusions in human leukocyte antigen antibody-positive patients undergoing haploidentical hematopoietic stem cell transplantation
by: Yuying Wang, et al.
Published: (2024-09-01)

Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia
by: Lixin Xu, et al.
Published: (2018-03-01)

Effectiveness of T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation for Refractory/Relapsed B Cell Acute Lymphoblastic Leukemia in Children and Adolescents
by: Hideki Sano, et al.
Published: (2021-10-01)

Editorial: Recent Developments in Haploidentical Hematopoietic Cell Transplantation: Therapy and Complications
by: Ying-Jun Chang, et al.
Published: (2021-08-01)

A comprehensive model to predict severe acute graft-versus-host disease in acute leukemia patients after haploidentical hematopoietic stem cell transplantation
by: Meng-Zhu Shen, et al.
Published: (2022-05-01)

The history of haploidentical stem cell transplantation: a trip from the bench to the bedside
by: Mariana G. Meade, et al.
Published: (2024-12-01)

Commentary: Post-Transplantation Cyclophosphamide Uniquely Restrains Alloreactive CD4+ T-Cell Proliferation and Differentiation After Murine MHC-Haploidentical Hematopoietic Cell Transplantation
by: Jessica Stokes, et al.
Published: (2022-04-01)

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
by: Bianca Serio, et al.
Published: (2024-04-01)

Two dose levels of rabbit antithymocyte globulin as graft-versus-host disease prophylaxis in haploidentical stem cell transplantation: a multicenter randomized study
by: Ren Lin, et al.
Published: (2019-08-01)

Haploidentical stem cell transplant: Established treatment, expanding horizons
by: Mukul Aggarwal, et al.
Published: (2016-01-01)

Is It Possible to Separate the Graft-Versus-Leukemia (GVL) Effect Against B Cell Acute Lymphoblastic Leukemia From Graft-Versus-Host Disease (GVHD) After Hematopoietic Cell Transplant?
by: Jacob Rozmus, et al.
Published: (2022-03-01)

Sphingolipid metabolism in T cell responses after allogeneic hematopoietic cell transplantation
by: Linlu Tian, et al.
Published: (2022-08-01)

Donor γδT Cells Promote GVL Effect and Mitigate aGVHD in Allogeneic Hematopoietic Stem Cell Transplantation
by: Yuan Song, et al.
Published: (2020-10-01)

Hematopoietic Stem Cell Transplantation—50 Years of Evolution and Future Perspectives
by: Israel Henig, et al.
Published: (2014-10-01)

Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from India
by: Pallavi Mehta, et al.

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)

The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia
by: Fan Lin, et al.
Published: (2022-05-01)

Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study
by: Meiqing Lei, et al.
Published: (2022-06-01)

Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease
by: Haitham Abdelhakim, et al.
Published: (2017-06-01)

Haploidentical Stem Cell Transplantation for Acute Myeloid Leukemia: Current Therapies, Challenges and Future Prospective
by: Ying-Jun Chang, et al.
Published: (2021-10-01)

Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?
by: Linde Dekker, et al.
Published: (2022-06-01)

Dual T-cell depletion with individually tailored anti-thymocyte globulin and attenuated dose of post-transplant cyclophosphamide in haploidentical peripheral stem cell transplantation
by: Dong Hyun Kim, et al.
Published: (2024-06-01)

NOTCH and Graft-Versus-Host Disease
by: Mauro Di Ianni, et al.
Published: (2018-08-01)

Immune reconstitution after hematopoietic stem cell transplantation
by: Justyna Ogonek, et al.
Published: (2016-11-01)

Advancing Allogeneic Hematopoietic Stem Cell Transplantation Outcomes through Immunotherapy: A Comprehensive Review of Optimizing Non-CAR Donor T-Lymphocyte Infusion Strategies
by: Stefania Braidotti, et al.
Published: (2024-08-01)

Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models
by: Yan Jiang, et al.
Published: (2023-12-01)

Graft-versus-host disease and other cutaneous manifestations in pediatric patients transplanted for Fanconi anemia
by: Leane Dhara Dalle Laste, et al.
Published: (2023-07-01)

Ocular graft-versus-host disease: An update on immune pathogenesis and therapies
by: Samantha P. Peña-Lozano, et al.
Published: (2022-07-01)

Sirolimus versus cyclosporine in haploidentical stem cell transplantation with posttransplant cyclophosphamide and mycophenolate mofetil as graft‐versus‐host disease prophylaxis
by: Rafael Hernani, et al.
Published: (2021-05-01)

The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation
by: Dolores Grosso, et al.
Published: (2019-09-01)

Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
by: Hannes Schmid, et al.
Published: (2018-08-01)

Scabies mimicking graft versus host disease in a hematopoietic cell transplant recipient
by: Dongsub Kim, et al.
Published: (2018-11-01)

Antithymocyte Globulin Plus Post-Transplant Cyclophosphamide Combination as an Effective Strategy for Graft-versus-Host Disease Prevention in Haploidentical Peripheral Blood Stem Cell Transplantation for Children with High-Risk Malignancies
by: Kang-Hsi Wu, et al.
Published: (2022-11-01)

Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients
by: Yu Wang, et al.
Published: (2019-09-01)

Immune Reconstitution after Haploidentical Donor and Umbilical Cord Blood Allogeneic Hematopoietic Cell Transplantation
by: Hany Elmariah, et al.
Published: (2021-01-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Current Approaches for the Prevention and Treatment of Acute and Chronic GVHD
by: Attilio Olivieri, et al.
Published: (2024-09-01)

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis
by: Maria Queralt Salas, et al.
Published: (2019-06-01)

Human umbilical cord-derived mesenchymal stromal cells for the treatment of steroid refractory grades III-IV acute graft-versus-host disease with long-term follow-up
by: Jing-wen Niu, et al.
Published: (2024-08-01)

Regulatory T-cells and allogeneic hematopoietic stem cell transplantation
by: O. S. Karavaeva, et al.
Published: (2022-12-01)